You are here

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
Miscellaneous
Journal club
A molecular assay to predict survival in resected non-squamous non-small-cell lung cancer
  1. Tin Myo Hlaing,
  2. Jeng-Shing Wang
  1. Correspondence to Dr Jeng-Shing Wang, Antai Medical Care Cooperation Antai Tian-Sheng Memorial Hospital, Department of Thoracic Medicine, Pingtung, & Department of Senior Citizen Service Management, Yuh-Ing Junior College, Kaohsiung, Pingtung 928, Taiwan; wangjs6{at}hotmail.com

https://doi.org/10.1136/thoraxjnl-2012-202055

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    This 14-gene expression assay that uses quantitative PCR on formalin-fixed paraffin-embedded tissue samples was developed and validated and compared with conventional staging. This assay was developed in patients with resected non-squamous non-small-cell lung cancer (NSCLC) at one centre, and then validated in patients with resected stage I non-squamous NSCLC …

    View Full Text

    Linked Articles

    • Correction
      Correction
      BMJ Publishing Group Ltd and British Thoracic Society
      Thorax 2013; 68 596-596 Published Online First: 08 May 2013. doi: 10.1136/thoraxjnl-2012-202055corr1